Staff Bios

*Articles published in peer-reviewed international journals scanned by SCI and SCI
extended:
*A1. Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C,
Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P,
Tiseo M, John T, Lin MC , Imamura F, Kurata T, Todd A, Hodge R, Saggese M,
Rukazenkov Y, Soria JC; FLAURA investigators. (……Sriuranpong V, Yildiz R,
Bondarenko I…..,) Overall survival with osimertinib in untreated, EGFR-mutated
advanced NSCLC. NEEngl J Med. 2020 Jan 2;382(1):41-50. doi:
10.1056/NEJMoa1913662.
*A2. Schmidinger M, Bamias A, Procopio G, Hawkins R, Sanchez AR, Vázquez S,
Srihari N, Kalofonos H, Bono P, Pisal CB, Hirschberg Y, Dezzani L, Ahmad Q, Jonasch
E; MAIN study group (….Wyendaele W, Yildiz R, Yucel I…). Prospective
observational study of pazopanib in patients with advanced renal cell carcinoma
(PRIMARY study)Oncologist. 2019 Apr;24(4):491-497. doi:
10.1634/theoncologist.2018-0787.
*A3. Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee
KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC,
Cheng Y, Cho EK, Voon PJ, Planchard D , Su WC, Gray JE, Lee SM, Hodge R, Marotti
M, Rukazenkov Y, Ramalingam SS; FLAURA researchers (Boyer M,…. Yildiz
R,…..Nguyen N.) Osimertinib in untreated advanced non-small cell lung cancer with
EGFR mutation. NEEngl J Med. 2018 Jan 11;378(2):113-125. doi:
10.1056/NEJMoa1713137.
*A4. Yalçın Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyılkan Ö, Sevinç A,
Özdemir F, Turna H, Uslu R, Ulay E. A national, multicenter, non-interventional
observational study of treatment regimens in patients with metastatic renal cell
carcinoma in Turkey – NOTES study. Onco targets Ther. 2018 Mar 5;11:1223-1228.
doi: 10.2147/OTT.S148917.
*AT 5. Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F,
Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B,
Maroto P, Heng DY, Schmidinger M , Kantoff PW, Borgman-Hagey A, Hessel C,
Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators (Tan H, …….,
Yildiz R, ……. Randall J.). Cabozantinib versus Everolimus in advanced renal cell
carcinoma. NEEngl J Med. 2015 Nov 5;373(19):1814-23. doi:
10.1056/NEJMoa1510016. Published online September 25, 2015. 

*

*1998 – Hacettepe University Faculty of Medicine (English)
*2004 – Specialization Training in Internal Medicine, Faculty of Medicine, İnönü University
*2009 – Minor Specialization Training in Medical Oncology, Faculty of Medicine, Gazi University
*2010 – Lecturer, Faculty of Medicine, Gazi University, Medical Oncology
*2012 – Associate Professor of Medical Oncology

*1999-2004: Specialization training in internal medicine, İnönü University Faculty of Medicine, Turgut Özal Medical Center
*2004- 2005: Specialist in internal medicine, Mus State Hospital
*2005- 2009: Minor specialization training in medical oncology, Faculty of Medicine, Gazi University,
*June 2015- November 2015: Roswell Park Cancer Center, Buffalo, New York, USA
*2008: Preceptorship with Eric Van Cutsem, University of Louvain, Belgium
*2008: Preceptorship with Fairoz Kabinavar, UCLA, Los Angeles, USA
*2009- 2010: Lecturer, Faculty of Medicine, University of Gazi,
*2010- 2012: Specialist in medical oncology, Dr. Lütfi Kirdar Kartal Training and Research Hospital,
*June 2012: Assoc. dr. Lütfi Kirdar Kartal Training and Research Hospital
*2013- 2016: Associ. Dr., Faculty Member, Gazi University Faculty of Medicine, Department of Internal Medicine, Department of Medical Oncology,
*2017-2020: Istinye University, Medical Park Elazig Hospital,
*2020-2021: Şişli Kolan International Hospital,
*2021-…: Istanbul Aydın University, VM Medical Park Florya Hospital